Chronic GVHD

8 registered clinical trials studyying Chronic GVHD.

Status	Trial	Sponsor	Phase
Withdrawn	Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated NCT05509582	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Active Not Recruiting	Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease NCT06458127	Massachusetts General Hospital	N/A
Terminated	Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias NCT05502783	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease NCT04294641	National Cancer Institute (NCI)	Phase 2
Completed	SHR0302 and Steroid As First Line Therapy for Chronic GVHD NCT04146207	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	EARLY_Phase 1
Active Not Recruiting	Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease NCT02611180	Washington University School of Medicine	—
Active Not Recruiting	Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disea NCT01937468	Dana-Farber Cancer Institute	Phase 1
Completed	Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) NCT01106833	Medical College of Wisconsin	Phase 2 / Phase 3